Document:

<PAGE>

                                                                   EXHIBIT 10.14
REVISED - APPENDIX A

                           RESTRICTED STOCK UNIT AWARD
                                THOMAS J. O'BRIEN
                    PERFORMANCE TARGETS AND VESTING SCHEDULE

I.       DEFINITIONS

         "Pre-Tax EPS Growth" shall mean growth in Pre-Tax EPS (as defined
below) as measured at the end of each fiscal year of the Performance Period.
Growth shall be measured off of the Base Year Adjusted Pre-Tax EPS.

         "Base Year" shall mean the Corporation's fiscal year ended May 26,
2002.

         "Base Year Adjusted Pre-Tax EPS" shall mean $.58.

         "Fully Diluted Shares" shall mean total diluted shares as reported in
the Company's Consolidated Income Statement for each fiscal year of the
Performance Period, but shall exclude the dilutive effect of any restricted
stock or restricted stock unit awards granted during the Performance Period and
all options, restricted stock and other equity compensation granted to Directors
during the Performance Period.

         "Investment Grade" shall mean an investment rating of not less than
BBB- or Baa3 by one of the major rating agencies (Standard and Poors, Moodys
Investor Service or Fitch). If, at the time of measurement, the Corporation's
debt is not rated, then it shall be considered Investment Grade.

         "Pre-Tax Earnings" shall mean the Corporation's earnings before income
taxes as reported in the Company's Consolidated Income Statement for each fiscal
year of the Performance Period, excluding any non-cash charge incurred in
accordance with accounting principles generally accepted in the United States of
America (GAAP) for any restricted stock or restricted stock unit awards granted
during the Performance Period and all options, restricted stock and other equity
compensation granted to Directors during the Performance Period.

         "Pre-Tax EPS" shall mean Pre-Tax Earnings divided by Fully Diluted
Shares.

II.      PERFORMANCE TARGETS
<TABLE>
<CAPTION>
----------------------------------------------------------------------------------------------------------------------
157,500 Restricted Units               56,250 Threshold      123,750 Intermediate               157,500 Stretch
----------------------------------------------------------------------------------------------------------------------
<S>                                     <C>                        <C>                          <C>
Growth                                  8% Compounded              11% Compounded               15% Compounded

----------------------------------------------------------------------------------------------------------------------
Corporation's debt must be Investment Grade at the end of the Performance
Period, and in any year in which vesting occurs.
----------------------------------------------------------------------------------------------------------------------
</TABLE>

<PAGE>
III.     VESTING SCHEDULE

The restrictions will lapse with respect to the corresponding number of
Restricted Units associated with the performance targets set forth in II above
based on the following schedule. This schedule shall be adjusted for any change
in the number or class of shares of Stock outstanding, by reason of a stock
dividend, stock split, subdivision or combination of shares.
<TABLE>
<CAPTION>
Year 3 allocation                EPS Growth      Share Alloc           x vesting          Shares earned
-----------------                ----------
<S>                             <C>
EPS $0.73 - $0.77                 8%-10.4%       56,250                      15%          8,438

EPS $0.78 - $0.87               10.5%-14.9%      123,750                     15%          18,563

EPS $0.88 +                         15%          157,500                     15%          23,625

Year 4 allocation                EPS Growth      Share Alloc           x vesting          Shares earned
-----------------                ----------

EPS $0.79 - $0.86                 8%-10.4%       56,250                      20%          11,250

EPS $0.87 - $1.00               10.5%-14.9%      123,750                     20%          24,750

EPS $1.01 +                         15%          157,500                     20%          31,500

Year 5 Allocation                                                                         Shares earned
-----------------

$0.85                               8.0%         56,250                     100%          56,250

$0.86                             8.1-8.3%       62,390                     100%          62,390

$0.87                             8.4-8.5%       68,520                     100%          68,520

$0.88                             8.6-8.8%       74,660                     100%          74,660

$0.89                             8.9-9.0%       80,800                     100%          80,800

$0.90                             9.1-9.3%       86,930                     100%          86,930

$0.91                             9.4-9.5%       93,070                     100%          93,070

$0.92                             9.6-9.7%       99,200                     100%          99,200

$0.93                            9.8-10.0%       105,340                    100%          105,340

$0.94                            10.1-10.2%      111,480                    100%          111,480
</TABLE>

<PAGE>
<TABLE>
<CAPTION>
Year 5 Allocation                                                                         Shares earned
<S>                              <C>
$0.95                            10.3-10.4%      117,610                    100%          117,610

$0.96                            10.5-10.7%      123,750                    100%          123,750

$0.97                            10.8-10.9%      125,360                    100%          125,360

$0.98                            11.0-11.1%      126,960                    100%          126,960

$0.99                            11.2-11.3%      128,570                    100%          128,570

$1.00                            11.4-11.6%      130,180                    100%          130,180

$1.01                            11.7-11.8%      131,790                    100%          131,790

$1.02                            11.9-12.0%      133,390                    100%          133,390

$1.03                            12.1-12.2%      135,000                    100%          135,000

$1.04                            12.3-12.4%      136,610                    100%          136,610

$1.05                            12.5-12.7%      138,210                    100%          138,210

$1.06                            12.8-12.9%      139,820                    100%          139,820

$1.07                            13.0-13.1%      141,430                    100%          141,430

$1.08                            13.2-13.3%      143,040                    100%          143,040

$1.09                            13.4-13.5%      144,640                    100%          144,640

$1.10                            13.6-13.7%      146,250                    100%          146,250

$1.11                            13.8-13.9%      147,860                    100%          147,860

$1.12                            14.0-14.1%      149,460                    100%          149,460

$1.13                            14.2-14.3%      149,460                    100%          149,460

$1.14                            14.4-14.5%      149,460                    100%          149,460

$1.15                            14.6-14.7%      149,460                    100%          149,460
</TABLE>

<PAGE>
<TABLE>
<CAPTION>
Year 5 Allocation                                                                         Shares earned
<S>                              <C>
$1.16                            14.8-14.9%      149,460                    100%          149,460

$1.17                              15.0%         157,500                    100%          157,500
</TABLE>

In the event of termination for a Qualified Reason, the number of shares earned
shall be measured at the end of the fiscal year in which the termination for a
Qualified Reason occurred, and shall be paid after the end of such fiscal year.
Accordingly, no Restricted Units will vest if termination occurs during fiscal
years 2003 or 2004.THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAW AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR ORTEC INTERNATIONAL, INC. SHALL HAVE RECEIVED AN OPINION OF ITS COUNSEL THAT REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT AND UNDER THE PROVISIONS OF APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED.

 

ORTEC INTERNATIONAL, INC.

 

PROMISSORY NOTE

 

 

	
            U.S. $250,000
 	
            New York, New York
 
	
            No.: PN-06-01
 	
            Issuance Date: March 15, 2006
 
	
             
	
            Maturity Date: April 30, 2006
 
				

 

FOR VALUE RECEIVED, the undersigned, Ortec International, Inc., a Delaware corporation (the "Company"), hereby promises to pay to the order of SDS Capital Group SPC, Ltd., or any future permitted holder of this promissory note (the "Payee"), at the principal office of the Payee set forth herein, or at such other place as the holder may designate in writing to the Company, the principal sum of Two Hundred and Fifty Thousand Dollars ($250,000) or such other amount as may be outstanding hereunder, together with all accrued but unpaid interest, in such coin or currency of the United States of America as at the time shall be legal tender for the payment of public and private debts and in immediately available funds, as provided in this promissory note (the "Note").  

 

1.          Automatic Conversion of Principal and Interest into Qualified Financing.  The outstanding principal amount of this Note, together with all accrued but unpaid interest hereunder (the “Outstanding Balance”), shall automatically convert into equity securities issued in an equity financing or a combination of equity financings with gross proceeds totaling at least $5,000,000 (the “Qualified Financing”), such conversion to be at the same price per equity security as the equity securities sold in the Qualified Financing; provided, however, that for purposes of determining the number of equity securities (including warrants) to be received by the Payee upon such conversion, the Payee shall be deemed to have tendered 120% of the Outstanding Balance of the Note as payment of the purchase price of such equity securities. In addition and upon conversion, the Company agrees to forego Payee’s obligation to fund an additional $808,000 under an earlier agreed upon funding commitment, but allow warrants earlier repriced upon the commitment to remain outstanding.

	
            2.
 	
            Principal and Interest Payments.  
 

(a)        In the event the Company does not complete the Qualified Financing, the Company shall repay the entire principal balance then outstanding on April 30, 2006 (the "Maturity Date"). 

 

 

(b)   Interest on the outstanding principal balance of this Note shall accrue at a rate of eight percent (8%) per annum.  Interest on the outstanding principal balance of the Note shall be computed on the basis of the actual number of days elapsed and a year of three hundred and sixty (360) days and shall be payable on the Maturity Date by the Company in cash or in shares of the Company’s equity securities.  Furthermore, upon the occurrence of an Event of Default, then to the extent permitted by law, the Company will pay interest to the Payee, payable on demand, on the outstanding principal balance of the Note from the date of the Event of Default until payment in full at the rate of twelve percent (12%) per annum.

(c)   At the Company’s sole option, the Company may prepay the outstanding principal amount of this Note plus all accrued and unpaid interest in cash at any time without penalty prior to maturity.  All payments made on account of the indebtedness evidenced by this Note shall be applied first to accrued but unpaid interest, if any, and the remainder shall be applied to principal.  

3.            Non-Business Days.  Whenever any payment to be made shall be due on a Saturday, Sunday or a public holiday under the laws of the State of New York, such payment may be due on the next succeeding business day and such next succeeding day shall be included in the calculation of the amount of accrued interest payable on such date.

4.            Representations and Warranties of the Company.  The Company represents and warrants to the Payee as follows:

(a)          The Company has been duly incorporated and is validly existing and in good standing under the laws of the state of Delaware, with full corporate power and authority to own, lease and operate its properties and to conduct its business as currently conducted.

(b)          This Note has been duly authorized, validly executed and delivered on behalf of the Company and is a valid and binding obligation of the Company enforceable against the Company in accordance with its terms, subject to limitations on enforcement by general principles of equity and by bankruptcy or other laws affecting the enforcement of creditors' rights generally, and the Company has full power and authority to execute and deliver this Note and to perform its obligations hereunder.

(c)          The execution, delivery and performance of this Note will not (i) conflict with or result in a breach of or a default under any of the terms or provisions of, (A) the Company's certificate of incorporation or by-laws, or (B) any material provision of any indenture, mortgage, deed of trust or other material agreement or instrument to which the Company is a party or by which it or any of its material properties or assets is bound, (ii) result in a violation of any material provision of any law, statute, rule, regulation, or any existing applicable decree, judgment or order by any court, Federal or state regulatory body, administrative agency, or other governmental body having jurisdiction over the Company, or any of its material properties or assets or (iii) result in the creation or
imposition of any material lien, charge or encumbrance upon any material property or assets of the Company or any of its subsidiaries pursuant to the terms of any agreement or instrument to which any of them is a party or by which any of them may be bound or to which any of their property or any of them is subject.   

(d)          No consent, approval or authorization of or designation, declaration or filing with any governmental authority on the part of the Company is required in connection with the valid execution and delivery of this Note.

 

 

5.            Events of Default.  The occurrence of any of the following events shall be an "Event of Default" under this Note:

(a)          the Company shall fail to make the payment of any amount of any principal outstanding for a period of three (3) business days after the date such payment shall become due and payable hereunder; or

(b)          the Company shall fail to make any payment of interest for a period of three (3) business days after the date such interest shall become due and payable hereunder; or

(c)          any representation, warranty or certification made by the Company herein or in any certificate or financial statement shall prove to have been false or incorrect or breached in a material respect on the date as of which made; or

(d)          the holder of any indebtedness of the Company or any of its subsidiaries shall accelerate any payment of any amount or amounts of principal or interest on any indebtedness (the "Indebtedness") (other than the Indebtedness hereunder) prior to its stated maturity or payment date the aggregate principal amount of which Indebtedness of all such persons is in excess of $1,000,000, whether such Indebtedness now exists or shall hereinafter be created, and such accelerated payment entitles the holder thereof to immediate payment of such Indebtedness which is due and owing and such indebtedness has not been discharged in full or such acceleration has not been stayed, rescinded or annulled within ten (10) business days of such acceleration; or  

(e)          A judgment or order for the payment of money shall be rendered against the Company or any of its subsidiaries in excess of $1,000,000 in the aggregate (net of any applicable insurance coverage) for all such judgments or orders against all such persons (treating any deductibles, self insurance or retention as not so covered) that shall not be discharged, and all such judgments and orders remain outstanding, and there shall be any period of sixty (60) consecutive days following entry of the judgment or order in excess of $1,000,000 or the judgment or order which causes the aggregate amount described above to exceed $1,000,000 during which a stay of enforcement of such judgment or order, by reason of a pending appeal or otherwise, shall not be in effect; or

(f)          the Company shall (i) apply for or consent to the appointment of, or the taking of possession by, a receiver, custodian, trustee or liquidator of itself or of all or a substantial part of its property or assets, (ii) make a general assignment for the benefit of its creditors, (iii) commence a voluntary case under the Bankruptcy Code or under the comparable laws of any jurisdiction (foreign or domestic), (iv) file a petition seeking to take advantage of any bankruptcy, insolvency, moratorium, reorganization or other similar law affecting the enforcement of creditors' rights generally, (v) acquiesce in writing to any petition filed against it in an involuntary case under the Bankruptcy Code or under the comparable laws of any jurisdiction (foreign or domestic), or (vi) take any action
under the laws of any jurisdiction (foreign or domestic) analogous to any of the foregoing; or

(g)          a proceeding or case shall be commenced in respect of the Company or any of its subsidiaries without its application or consent, in any court of competent jurisdiction, seeking (i) the liquidation, reorganization, moratorium, dissolution, winding up, or composition or readjustment of its debts, (ii) the appointment of a trustee, receiver, custodian, liquidator or the like of it or of all or any substantial part of its assets or (iii) similar relief in respect of it under any law providing for the relief of debtors, and such proceeding or case described in clause (i), (ii) or (iii) shall continue undismissed, or unstayed and in effect, for a period of thirty (30) consecutive days or any order for relief shall be entered in an involuntary case under the Bankruptcy Code or under the
comparable laws of any jurisdiction 

 

(foreign or domestic) against the Company or any of its subsidiaries or action under the laws of any jurisdiction (foreign or domestic) analogous to any of the foregoing shall be taken with respect to the Company or any of its subsidiaries and shall continue undismissed, or unstayed and in effect for a period of thirty (30) consecutive days; or

(h)          the suspension from listing or the failure of the Common Stock to be listed on the OTC Bulletin Board for a period of five (5) consecutive trading days.

6.            Remedies Upon An Event of Default.  If an Event of Default shall have occurred and shall be continuing, the Payee of this Note may at any time at its option, (a) declare the entire unpaid principal balance of this Note, together with all interest accrued hereon, due and payable, and thereupon, the same shall be accelerated and so due and payable; provided, however, that upon the occurrence of an Event of Default described in (i) Sections 5(f) and (g), without presentment, demand, protest, or notice, all of which are hereby expressly unconditionally and irrevocably waived by the Company, the outstanding principal balance and accrued interest hereunder shall be
automatically due and payable, and (ii) Sections 5(a) through (e) and Section 5(h), the Payee may exercise or otherwise enforce any one or more of the Payee's rights, powers, privileges, remedies and interests under this Note or applicable law.  No course of delay on the part of the Payee shall operate as a waiver thereof or otherwise prejudice the right of the Payee.  No remedy conferred hereby shall be exclusive of any other remedy referred to herein or now or hereafter available at law, in equity, by statute or otherwise.  Notwithstanding the foregoing, Payee agrees that its rights and remedies hereunder are limited to receipt of cash or shares of the Company’s equity securities in the amounts described herein.

7.            Replacement.  Upon receipt of a duly executed, notarized and unsecured written statement from the Payee with respect to the loss, theft or destruction of this Note (or any replacement hereof), and without requiring an indemnity bond or other security, or, in the case of a mutilation of this Note, upon surrender and cancellation of such Note, the Company shall issue a new Note, of like tenor and amount, in lieu of such lost, stolen, destroyed or mutilated Note.

8.            Parties in Interest, Transferability.  This Note shall be binding upon the Company and its successors and assigns and the terms hereof shall inure to the benefit of the Payee and its successors and permitted assigns. This Note may be transferred or sold, subject to the provisions of Section 17 of this Note, or pledged, hypothecated or otherwise granted as security by the Payee.

9.            Amendments.  This Note may not be modified or amended in any manner except in writing executed by the Company and the Payee.

10.         Notices.  Any notice, demand, request, waiver or other communication required or permitted to be given hereunder shall be in writing and shall be effective (a) upon hand delivery by telecopy or facsimile at the address or number designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur.  The Company will give written notice to the Payee at least thirty (30)
days prior to the date on which the Company closes its books or takes a record (x) with respect to any dividend or distribution upon the common stock of the Company, (y) with respect to any pro rata subscription offer to holders of common stock of the Company or (z) for determining rights to vote with respect to a Major Transaction, dissolution, liquidation or winding-up and in no event shall such notice be provided to such holder prior to such information being made known to the public.  The Company will also give written notice to the 

 

Payee at least twenty (20) days prior to the date on which dissolution, liquidation or winding-up will take place and in no event shall such notice be provided to the Payee prior to such information being made known to the public.

	
            Address of the Payee:
 	
            SDS Capital Group SPC LTD
 

c/o SDS Management LLC

Attention: Scott Derby

53 Forest Ave, Suite 203

Old Greenwich, CT 06870

	
            Fax No.: (203) 967-5851
 

 

 

	
             
 	
            With a copy to:
 	
            Kramer Levin Naftalis & Frankel LLP
 

 

	
            1177 Avenue of the Americas
 

New York, New York 10036

	
            Attention:  Christopher S. Auguste
 
	
            Tel. No.: (212) 715-9265
 	
             

	
            Fax No.: (212) 715-8277
 	
             

			

 

	
            Address of the Company:
 	
            Ortec International, Inc.
 	
             

	
             
	
            3960 Broadway
 	
             

	
             
	
            New York, New York 10032
 	
             

	
             
	
            Attention: Chief Financial Officer
 
	
             
	
            Tel. No.: (212) 740-6999
 	
             

	
             
	
            Fax No.:  (212) 740-2570
 	
             

							

 

	
            With a copy to:
 	
            Feder, Kaszovitz, Issacson, Weber, Skala, Bass & Rhine LLP
 
	
             
	
            750 Lexington Ave.
 	
             

	
             
	
            New York, New York 10022
 	
             

	
             
	
            Attention: Gabriel Kaszovitz, Esq.
 	
             

	
             
	
            Tel. No.:  (212) 888-8200
 	
             

						

Fax No.:  (212) 888-7776

 

11.         Governing Law. This Note shall be governed by and construed in accordance with the internal laws of the State of New York, without giving effect to the choice of law provisions.  This Note shall not be interpreted or construed with any presumption against the party causing this Note to be drafted.

12.         Headings.  Article and section headings in this Note are included herein for purposes of convenience of reference only and shall not constitute a part of this Note for any other purpose.

13.         Remedies, Characterizations, Other Obligations, Breaches and Injunctive Relief.  The remedies provided in this Note shall be cumulative and in addition to all other remedies available under this Note, at law or in equity (including, without limitation, a decree of specific performance and/or other injunctive relief), no remedy contained herein shall be deemed a waiver of compliance with the provisions giving rise to such remedy and nothing herein shall limit a Payee's right to pursue actual damages for any failure by the Company to comply with the terms of this Note.  Amounts set forth or provided for herein with respect to payments and the like (and the computation thereof) shall be the amounts to be received by the Payee and shall not, except as expressly provided
herein, be subject to any other obligation of the Company (or the performance thereof).  The Company acknowledges that a breach 

 

by it of its obligations hereunder will cause irreparable and material harm to the Payee and that the remedy at law for any such breach may be inadequate.  Therefore the Company agrees that, in the event of any such breach or threatened breach, the Payee shall be entitled, in addition to all other available rights and remedies, at law or in equity, to seek and obtain such equitable relief, including but not limited to an injunction restraining any such breach or threatened breach, without the necessity of showing economic loss and without any bond or other security being required.

14.         Failure or Indulgence Not Waiver.  No failure or delay on the part of the Payee in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privilege.

15.         Enforcement Expenses.  The Company agrees to pay all costs and expenses of enforcement of this Note, including, without limitation, reasonable attorneys' fees and expenses.

16.         Binding Effect.   The obligations of the Company and the Payee set forth herein shall be binding upon the successors and assigns of each such party, whether or not such successors or assigns are permitted by the terms hereof.

17.         Compliance with Securities Laws.  The Payee of this Note acknowledges that this Note is being acquired solely for the Payee's own account and not as a nominee for any other party, and for investment, and that the Payee shall not offer, sell or otherwise dispose of this Note other than in compliance with the laws of the United States of America and as guided by the rules of the Securities and Exchange Commission.  This Note and any Note issued in substitution or replacement therefore shall be stamped or imprinted with a legend in substantially the following form:

"THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAW AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT AND UNDER APPLICABLE STATE SECURITIES LAWS OR ORTEC INTERNATIONAL, INC. SHALL HAVE RECEIVED AN OPINION OF ITS COUNSEL THAT REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT AND UNDER THE PROVISIONS OF APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED."

 

18.         Severability.  The provisions of this Note are severable, and if any provision shall be held invalid or unenforceable in whole or in part in any jurisdiction, then such invalidity or unenforceability shall not in any manner affect such provision in any other jurisdiction or any other provision of this Note in any jurisdiction.

19.         Consent to Jurisdiction.  Each of the Company and the Payee (i) hereby irrevocably submits to the jurisdiction of the United States District Court sitting in the Southern District of New York and the courts of the State of New York located in New York County for the purposes of any suit, action or proceeding arising out of or relating to this Note and (ii) hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit, action or proceeding is improper.  Each of the Company and the Payee consents to process being 

 

served in any such suit, action or proceeding by mailing a copy thereof to such party at the address set forth in Section 10 hereof and agrees that such service shall constitute good and sufficient service of process and notice thereof.  Nothing in this Section 19 shall affect or limit any right to serve process in any other manner permitted by law.

20.         Company Waivers.  Except as otherwise specifically provided herein, the Company and all others that may become liable for all or any part of the obligations evidenced by this Note, hereby waive presentment, demand, notice of nonpayment, protest and all other demands and notices in connection with the delivery, acceptance, performance and enforcement of this Note, and do hereby consent to any number of renewals of extensions of the time or payment hereof and agree that any such renewals or extensions may be made without notice to any such persons and without affecting their liability herein and do further consent to the release of any person liable hereon, all without affecting the liability of the other persons, firms or Company liable for the payment of this Note,
AND DO HEREBY WAIVE TRIAL BY JURY.

(a)          No delay or omission on the part of the Payee in exercising its rights under this Note, or course of conduct relating hereto, shall operate as a waiver of such rights or any other right of the Payee, nor shall any waiver by the Payee of any such right or rights on any one occasion be deemed a waiver of the same right or rights on any future occasion.

(b)          THE COMPANY ACKNOWLEDGES THAT THE TRANSACTION OF WHICH THIS NOTE IS A PART IS A COMMERCIAL TRANSACTION, AND TO THE EXTENT ALLOWED BY APPLICABLE LAW, HEREBY WAIVES ITS RIGHT TO NOTICE AND HEARING WITH RESPECT TO ANY PREJUDGMENT REMEDY WHICH THE PAYEE OR ITS SUCCESSORS OR ASSIGNS MAY DESIRE TO USE.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

 

IN WITNESS WHEREOF, the Company has executed and delivered this Note as of the date first written above.

 

ORTEC INTERNATIONAL, INC.

 

 

	
            By: /s/ Alan W. Schoenbart
 	
             

	
             
	
            Name:  Alan W. Schoenbart, CFO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00101-of-00352.parquet"}]]